Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anlotinib in Advanced Soft Tissue Sarcoma
NCT01878448Phase 2Completed
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Apr 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anlotinib in soft tissue sarcoma (STS), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Apr 2013; status: completed.
02
Drugs
anlotinib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT01878448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01878448.